Zobrazeno 1 - 7
of 7
pro vyhledávání: '"I A, Komisarenko"'
Autor:
O M Mikheeva, I A Komisarenko
Publikováno v:
Системные гипертензии, Vol 11, Iss 3, Pp 83-87 (2014)
Beta-adrenergic blocking agent is included in the group of primary agentsfor treatment of patients with AH. In the pathogenesis of AH,one of the main causes leading to raisingthe blood pressure isendothelial dysfunction.Correction ofendothelial dysfu
Externí odkaz:
https://doaj.org/article/bcd213267fb0452897a56b81377faf52
Autor:
Ol'ga Mikhaylovna Mikheeva, Vladimir Nikolaevich Drozdov, Irina Arsen'evna Komisarenko, O M Mikheeva, V N Drozdov, I A Komisarenko
Publikováno v:
Терапевтический архив, Vol 83, Iss 12, Pp 49-55 (2011)
Aim. To determine optimal treatment of arterial hypertension (AH) in patients with hepatic cirrhosis (HC) basing on pharmacokinetic and pharmacodynamic characteristics of angiotensin-converting enzyme (ACE) inhibitors and beta-adrenoblockers (BAB). M
Externí odkaz:
https://doaj.org/article/a1ee0268524e4331835dc5a2c717303d
Autor:
Valentina Ivanovna Kas'yanenko, Irina Arsen'evna Komisarenko, Elena Anatol'evna Dubtsova, V I Kasianenko, I A Komisarenko, E A Dubtsova
Publikováno v:
Терапевтический архив, Vol 83, Iss 8, Pp 58-62 (2011)
Aim. To assess efficacy of treatment of patients with atherogenic dyslipidemia (ADL) with beekeeping products (honey, pollen, bee bread). Material and methods. ADL parameters were examined in 157 patients (64 males and 93 females) aged 39 to 72 (mean
Externí odkaz:
https://doaj.org/article/a130b1f6b38b445493dc4730847afc2a
Autor:
I A Komisarenko, Mikheeva Om
Publikováno v:
Systemic Hypertension. 11
Beta-adrenergic blocking agent is included in the group of primary agentsfor treatment of patients with AH. In the pathogenesis of AH,one of the main causes leading to raisingthe blood pressure isendothelial dysfunction.Correction ofendothelial dysfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e26dd821bf11e1bc2174b9bae18c3bad
https://doi.org/10.26442/2075-082x_11.3.83-87
https://doi.org/10.26442/2075-082x_11.3.83-87
Publikováno v:
Terapevticheskii arkhiv. 83(12)
To determine optimal treatment of arterial hypertension (AH) in patients with hepatic cirrhosis (HC) basing on pharmacokinetic and pharmacodynamic characteristics of angiotensin-converting enzyme (ACE) inhibitors and beta-adrenoblockers (BAB).A total
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0dacab1a18490cef2a5a574e91566b1e
https://pubmed.ncbi.nlm.nih.gov/22416445
https://pubmed.ncbi.nlm.nih.gov/22416445
Publikováno v:
Terapevticheskii arkhiv. 83(8)
To assess efficacy of treatment of patients with atherogenic dyslipidemia (ADL) with beekeeping products (honey, pollen, bee bread).ADL parameters were examined in 157 patients (64 males and 93 females) aged 39 to 72 (mean age 61,7 + 8,5 years) with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b79d943b825bdafd4930cea939339e44
https://pubmed.ncbi.nlm.nih.gov/21961335
https://pubmed.ncbi.nlm.nih.gov/21961335
Publikováno v:
Klinichna khirurhiia. (2)
More then ten year follow up of 154 patients with Itsenko-Cushing disease (ICD) is presented, of whom in 69-one sided and in 89-bilateral transcatheteric transvenous adrenal glands destruction (TTAGD) was done. In 50% of them the remission of disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae4a0206bd684b6e6a4c869972ab806f
https://pubmed.ncbi.nlm.nih.gov/9424280
https://pubmed.ncbi.nlm.nih.gov/9424280